| Literature DB >> 30254918 |
Min-Min Hou1, Lian Xu2, Ming-Rong Qie1.
Abstract
Choriocarcinoma is a rare pregnancy-related malignancy. The majority is arising from non-molar pregnancy. Here we report a patient who was diagnosed with postmolar choriocarcinoma after an interval of 7 years. Before surgery, we suspected the diagnosis of the patient was intramural pregnancy or choriocarcinoma. Laparoscopy was performed and hysterectomy was carried out. Postoperative pathological evaluation of the surgical specimen confirmed the case was choriocarcinoma. Hysterectomy through laparoscopy was feasible and safe for selected patients.Entities:
Keywords: Choriocarcinoma; Hysterectomy; Laparoscopy
Year: 2017 PMID: 30254918 PMCID: PMC6135188 DOI: 10.1016/j.gmit.2017.07.002
Source DB: PubMed Journal: Gynecol Minim Invasive Ther ISSN: 2213-3070
Fig. 1The ultrasonography showed an heterogenic mass with high blood flow and low resistance vascularity.
Fig. 2The CT scan showed a low density lesion on the upper posterior uterine wall that was no clear boundary from uterine myometrium and rectum serous layer.
Fig. 3The pathological findings were uterine choriocarcinoma accompanied with extensive hemorrhage and necrosis.
Staging for gestational trophoblastic neoplasia.
| Stage | Description |
|---|---|
| I | Disease confined to uterus |
| II | Disease extends outside uterus but is limited to genital structures (adnexa, vagina, broad ligament) |
| III | Disease extends to lungs with or without genital tract involvement |
| IV | Disease involves other metastatic sites |
Lurain. Gestational trophoblastic disease II. Am J Obstet Gynecol 2011.1
Scoring system for gestational trophoblastic neoplasia.
| FIGO/WHO risk factor scoring with stage | Score | |||
|---|---|---|---|---|
| 0 | 1 | 2 | 4 | |
| Age | ≤40 | >40 | – | – |
| Antecedent pregnancy | Mole | Abortion | Term | |
| Interval from index pregnancy, months | <4 | 4–6 | 7–12 | >12 |
| Pretreatment hCG, mIU/ml | <103 | 103–104 | 104–105 | >105 |
| Largest tumor mass, including uterus, cm | <3 | 3–4 | ≥5 | – |
| Site of metastases including uterus | Lung | Spleen, kidney | GI tract | Brain, liver |
| No. of metastases | – | 1–4 | 5–8 | >8 |
| Previous failed chemotherapy | – | – | Single drug | ≥2 drugs |
GI, gastrointestinal; hCG, human chorionic gonadotropin.
Total score for patient is obtained by adding individual scores for each prognostic factor: low risk ≤ 6; high risk > 6.
Ngan H.Y., Seckl M.J., Berkowitz R.S., et al. Update on the diagnosis and treatment of gestational trophoblastic disease. Internal Journal of Gynecology and Obstetrics 131 (2015):s123–s126.24